Emergence of metallo-β-lactamases in the Netherlands

Journal of Medical Microbiology

Volumn 58, Issue 10, 2009, Pages 1398-1399

  Al Naiemi, Nashwan ^a   Rijnsburger, Martine C ^a   Savelkoul, Paul H M ^a   Vandenbroucke Grauls, Christina M J ^a   Debets Ossenkopp, Yvette J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEMASE; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NORFLOXACIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ENTEROBACTERIACEAE; GENE CASSETTE; GENETIC VARIABILITY; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; EPIDEMIOLOGY, MOLECULAR; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 70349316373     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.011874-0     Document Type: Letter

References (11)

1. VIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother 61, 515-523.
2. Biendo, M., Canarelli, B., Thomas, D., Rousseau, F., Hamdad, F., Adjide, C., Laurans, G. & Eb, F. (2008). Successive emergence of extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J Clin Microbiol 46, 1037-1044.
3. Cagnacci, S., Gualco, L., Roveta, S., Mannelli, S., Borgianni, L., Docquier, J. D., Dodi, F., Centanaro, M., Debbia, E. & other authors (2008). Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak. J Antimicrob Chemother 61, 296-300.
4. Corvec, S., Poirel, L., Espaze, E., Giraudeau, C., Drugeon, H. & Nordmann, P. (2008). Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme. J Hosp Infect 68, 73-82.
5. SHV-5 in a French university hospital. J Antimicrob Chemother 57, 142-145.
6. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49, 4485-4491.
7. IMP-16, and a fused form of aminoglycoside-resistant gene aac(6′)-30/aac(6′)-Ib′: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 48, 4693-4702.
8. Paterson, D. L. (2008). Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. Clin Infect Dis 47 (Suppl. 1), S14-S20.
9. IMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 41, 1549-1556.
10. Tato, M., Coque, T. M., Ruiz-Garbajosa, P., Pintado, V., Cobo, J., Sader, H. S., Jones, R. N., Baquero, F. & Canton, R. (2007). Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-β-lactamase in Spain: toward endemicity? Clin Infect Dis 45, 1171-1178.
11. Zavascki, A. P., Barth, A. L., Goncalves, A. L., Moro, A. L., Fernandes, J. F., Martins, A. F., Ramos, F. & Goldani, L. Z. (2006). The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 58, 387-392. (Pubitemid 44294952)